The role of community pharmacists in public health: A scoping review of the literature

Journal of Pharmaceutical Health Services Research

Volumn 3, Issue 1, 2012, Pages 25-33

  Agomo, Chijioke O ^a  

^a Coagg Limited ^*  (United Kingdom)

Author keywords

Community pharmacists; Health services; Pharmaceutical services; Pharmacy; Public health; Scoping review

Indexed keywords

ARTICLE; BIOLOGICAL WARFARE; BLOOD PRESSURE REGULATION; CLIMATE CHANGE; COMMUNITY CARE; ELECTRONIC MEDICAL RECORD; EMERGENCY CARE; EVIDENCE BASED PRACTICE; FEEDING BEHAVIOR; HORMONAL CONTRACEPTION; HUMAN; IMMUNIZATION; INFECTION CONTROL; INFECTION PREVENTION; LIFESTYLE; MEDICAL LITERATURE; PANDEMIC; PHARMACIST; PHARMACIST ATTITUDE; PRIORITY JOURNAL; PUBLIC HEALTH; UNITED KINGDOM; VACCINATION;

EID: 84857080102     PISSN: 17598885     EISSN: 17598893     Source Type: Journal    
DOI: 10.1111/j.1759-8893.2011.00074.x     Document Type: Article

References (84)

1. Department of Health. Saving Lives: Our Healthier Nation. London: Stationery Office, 1999.
2. Department of Health. Healthy Lives, Healthy People: Our Strategy for Public Health in England. Norwich: Stationery Office, 2010.
3. Department of Health. Choosing Health through Pharmacy - A Programme for Pharmaceutical Public Health 2005-2015. London: DoH, 2005.
4. Department of Health. Pharmacy in England: Building on Strengths - Delivering the Future. Cm7341. London: Stationery Office, 2008.
5. McGuire TR etal. Accessing rural populations: role of the community pharmacist in a breast and cervical cancer screening programme. J Eval Clin Pract 2007; 13: 146-149.
6. Department of Health. Equity and Excellence: Liberating the NHS. Norwich: Stationery Office, 2010.
7. Bjorkman I etal. Health promotion at Swedish pharmacies - views of the staff. Pharm Pract 2008; 6: 211-218.
8. Arksey H, O'Malley L. Scoping studies: towards a methodological framework. Int J Soc Res Methodol 2005; 8: 19-32.
9. Ritchie J, Spencer L. Qualitative data analysis for applied policy research. In: Bryman A, Burgess RG, eds. Analysing Qualitative Data. London: Routledge, 1994: 173-194.
10. Anderson C etal. Feedback from community pharmacy users on the contribution of community pharmacy to improving the public's health: a systematic review of the peer reviewed and non-peer reviewed literature 1990-2002. Health Expect 2004; 7: 191-202.
11. Swanton K, Frost M. Lightening the Load: Tackling Overweight and Obesity - A Toolkit for Developing Local Strategies to Tackle Overweight and Obesity in Children and Adults. London: National Heart Forum, Faculty of Public Health & Department of Health, 2007.
12. Armstrong M. Pharmacists improving health - update from PharmacyHealthLink. 2007; (accessed 27 October 2011).
13. Department of Health. Developing the Pharmaceutical Public Health Workforce. London: DoH, 2001.
14. Department of Health. Pharmacy for Fellas. London: DoH, 2004.
15. Maryon-Davis A, Press V. Easing the Pressure: Tackling Hypertension - A Toolkit for Developing A Local Strategy to Tackle High Blood Pressure. London: Faculty of Public Health & National Heart Forum, 2005.
16. Ryan M. Folic acid to prevent neural tube defects: a potential pharmacy initiative with public health implications. Hosp Pharm 2004; 39: 962-969.
17. Blenkinsopp A etal. Evaluation of feasibility and acceptability of a community pharmacy health promotion scheme - views of users and providers. Health Educ J 2002; 61: 52-69.
18. Kotecki JE etal. Health promotion beliefs and practices among pharmacists. J Am Pharm Assoc 2000; 40: 773-779.
19. Sunderland B etal. Rural pharmacy not delivering on its health promotion potential. Aust J Rural Health 2006; 14: 116-119.
20. Adams A, Stafford L. Lancashire pharmacists are rising to the 'leading across boundaries' challenge. Pharm J 2008; 281: 306-307.
21. Grabenstein JD. Pharmacists as vaccine advocates: roles in community pharmacies, nursing homes, and hospitals. Vaccine 1998; 16: 1705-1710.
22. Grabenstein JD. How to explain vaccines to children and other inquisitive people. Hosp Pharm 1999; 34: 1421-1435.
23. Hogue MD etal. Pharmacist involvement with immunizations: a decade of professional advancement. J Am Pharm Assoc (Wash DC) 2006; 46: 168-182.
24. Westrick SC, Mount JK. Impact of perceived innovation characteristics on adoption of pharmacy-based in-house immunization services. Int J Pharm Pract 2009; 17: 39-46.
25. Anderson C, Blenkinsopp A. Community pharmacy's contribution to improving public health: learning from local initiatives. Pharm J 2003; 271: 623-625.
26. Bigbee JL etal. Pharmacy access to emergency contraception in rural and frontier communities. J Rural Health 2007; 23: 294-298.
27. Marciante KD etal. Modelling the cost and outcomes of pharmacist-prescribed emergency contraception. Am J Public Health 2001; 91: 1443-1445.
28. Raine TR etal. Direct access to emergency contraception through pharmacies and effect on unintended pregnancy and STIs: a randomized controlled trial. J Am Med Assoc 2005; 293: 54-62.
29. Peremans L etal. How does a Belgian health care provider deal with a request for emergency contraception? Eur J Contracept Reprod Health Care 2007; 12: 317-325.
30. O'Brien K. Helping to reduce health inequalities: community pharmacy can rise to the challenge and reduce health inequalities. Pharm J 2009; 283: 12.
31. Anderson C, Blenkinsopp A. Community pharmacy supply of emergency hormonal contraception: a structured literature review of international evidence. Hum Reprod 2006; 21: 272-284.
32. Soon JA etal. The developing role of pharmacists in patient access to emergency contraception. Dis Manag Health Outcome 2002; 10: 601-611.
33. Watson MC, Blenkinsopp A. The feasibility of providing community pharmacy-based services for alcohol misuse: a literature review. Int J Pharm Pract 2009; 17: 199-205.
34. Dhital R. Feasibility and usefulness of setting up an alcohol screening service in community pharmacy. MSc dissertation, University College London, 2004.
35. Fitzgerald N, Stewart D. Drinking Interventions in Pharmacies Study (DIPS). 2006; (accessed 27 October 2011).
36. Bammer G etal. Fast-tracking implementation through trial design: the case of buprenorphine treatment in Victoria. Aust NZ J Public Health 2009; 33: 34-39.
37. Britton RM, Scott J. Community pharmacy services to drug misusers in the south west of England: results of the 2003-2004 postal survey. Int J Pharm Pract 2006; 14: 235-241.
38. Le PP, Hotham ED. Exploring the dissonance between business and public health policy: pharmacy and the provision of opioid pharmacotherapies and clean needles in rural settings. Int J Pharm Pract 2006; 14: 63-70.
39. Peterson GM etal. Harm minimization strategies: opinions of health professionals in rural and remote Australia. J Clin Pharm Ther 2007; 32: 497-504.
40. Victorri-Vigneau C etal. How a novel programme for increasing awareness of health professionals resulted in a 14% decrease in patients using excessive doses of psychotropic drugs in western France. Eur J Clin Pharmacol 2006; 62: 311-316.
41. Hale KM etal. Pharmacist roles in combating prescription drug abuse. J Am Pharm Assoc (Wash DC) 2009; 49: 589-592.
42. Sinclair H, Lennox AS. Support from pharmacies can help people stop smoking. Br Med J 2001; 322: 52.
43. West R etal. Impact of UK policy initiatives on use of medicines to aid smoking cessation. Tob Control 2005; 14: 166-171.
44. Bellingham C. Kiss smoking goodbye - how pharmacists can help. Pharm J 2001; 266:319-321.
45. Hudmon KS etal. Reducing pulmonary disease: the pharmacist's role in smoking cessation. J Pharm Pract 2001; 14: 143-159.
46. Vitale F. Professional intervention for smoking cessation: the contribution of the pharmacist. Eur J Public Health 2000; 10: 21-24.
47. Babar ZU etal. A preliminary study on the effect of pharmacist counselling on awareness of and willingness to quit smoking in Malaysian population. Pharm World Sci 2007; 29: 101-103.
48. Calgan Z etal. Community pharmacists' attitude, habits and actual activities regarding smoking and health promotion in the 1. Region of Ankara chamber of pharmacists. Turkish J Pharm Sci 2007; 4: 125-138.
49. Dent LA etal. Randomized trial assessing the effectiveness of a pharmacist-delivered program for smoking cessation. Ann Pharmacother 2009; 43: 194-201.
50. Bruce L, Scott J. Practical advice on medical complications of intravenous drug misuse. Pharm J 1998; 260: 957-961.
51. Watson L etal. A survey of community pharmacists on prevention of HIV and hepatitis B and C: current practice and attitudes in Grampian. J Public Health Med 2003; 25: 13-18.
52. Oke TO. The role of pharmacists in AIDS care delivery. AIDS Patient Care 1995; 9: 75-77.
53. Vuylsteke B etal. Quality of sexually transmitted infections services for female sex workers in Abidjan, Cote d'Ivoire. Trop Med Int Health 2004; 9: 638-643.
54. Fuller CM etal. Multilevel community-based intervention to increase access to sterile syringes among injection drug users through pharmacy sales in New York City. Am J Public Health 2007; 97: 117-124.
55. McKay A. The effectiveness of latex condoms for prevention of STI/HIV. Can J Hum Sex 2007; 16: 57-61.
56. Boyle TC etal. Men's health initiative risk assessment study: effect of community pharmacy-based screening. J Am Pharm Assoc (Wash DC) 2004; 44: 569-577.
57. Chaiyakunapruk N etal. Community pharmacy-based implementation and evaluation of an Osteoporosis Self-assessment Tool for Asians. J Am Pharm Assoc (Wash DC) 2006; 46: 391-396.
58. Hunter TS. Prevention and treatment of osteoporosis in managed care settings. J Manag Care Pharm 2002; 8: 58-65.
59. Pora VV etal. Promoting cardiovascular health among older adults: a pilot study with community pharmacists. Can Pharm J 2005; 138: 50-55.
60. De Lyra DP Jr etal. Effect of pharmaceutical care intervention on blood pressure of elderly outpatients with hypertension. Revista Brasileira de Ciencias Farmaceuticas. Braz J Pharm Sci 2008; 44: 451-457.
61. Jones C etal. Enhancing hypertension awareness and management in the elderly: lessons learned from the Airdrie Community Hypertension Awareness and Management Program (A-CHAMP). Can J Cardiol 2008; 24: 561-567.
62. McLean DL etal. Improving blood pressure management in patients with diabetes: the design of the SCRIP-HTN study. Can Pharm J 2006; 139: 36-39.
63. Tsuyuki RT etal. A randomized trial of the effect of community pharmacist intervention on cholesterol risk management: the Study of Cardiovascular Risk Intervention by Pharmacists (SCRIP). Arch Intern Med 2002; 162: 1149-1155.
64. Huckerby C etal. Taking health care into black and minority communities - a pharmacist-led initiative. Pharm J 2006; 276: 680-682.
65. Limona D. Injuries and the cost of falls among older adults how pharmacists can help. J Pharm Pract 2009; 22: 344-345.
66. Wilson S etal. Prevalence of the use of cancer related self-tests by members of the public: a community survey. BMC Cancer 2006; 6: 215.
67. Hunter DJ etal. The Public Health System in England: A Scoping Study. Durham: Centre for Public Policy and Health, 2007.
68. Dahlgren G, Whitehead M. Policies and Strategies to Promote Social Equity in Health. Stockholm: Institute of Futures Studies, 1991.
69. Gilmore GD etal. An assessment of emergency preparedness in Western Wisconsin. Wis Med J 2007; 106: 71-77.
70. Massoomi F. Pharmacists in the Omaha Metropolitan Medical Response System. Am J Health Syst Pharm 2005; 62: 1290-1298.
71. Pedersen CA etal. Pharmacists' opinions regarding level of involvement in emergency preparedness and response. J Am Pharm Assoc (Wash DC) 2003; 43: 694-701.
72. Grabenstein J. The Pharmacist's response to biological or chemical terrorism: developing a preparedness plan. Hosp Pharm 1998; 33: 1423-1431.
73. Ursell VC etal. Community pharmacy involvement in public health provision: current perceptions and future directions. Pharm J 1999; 263: R53.
74. Anderson C etal. Pharmacists' perceptions regarding their contribution to improving the public's health: a systematic review of the United Kingdom and international literature 1990-2001. Int J Pharm Pract 2003; 11: 111-120.
75. Pfleger DE etal. Views, attitudes and self-assessed training needs of Scottish community pharmacists to public health practice and competence. Pharm World Sci 2008; 30: 801-809.
76. Anderson S. Community pharmacy and public health in Great Britain, 1936 to 2006: how a phoenix rose from the ashes. J Epidemiol Community Health 2007; 61: 844-848.
77. Wright M. EHC: enhancing the nation's well-being. Pharm J 2007; 278: 19.
78. Moberly T. Prescription-linked public health. Pharm J 2007; 278: 15-16.
79. King M etal. The Middlefield project - novel provision of pharmacy services to a deprived city area. Pharm J 2005; 275: 164-166.
80. Babb VJ, Babb J. Pharmacist involvement in healthy people 2010. J Am Pharm Assoc 2003; 43: 56-60.
81. Blenkinsopp A etal. Systematic review of the effectiveness of community pharmacy-based interventions to reduce risk behaviours and risk factors for coronary heart disease. J Public Health Med 2003; 25: 144-115.
82. O'Loughlin J etal. The role of community pharmacists in health education and disease prevention: a survey of their interests and needs in relation to cardiovascular disease. Prev Med 1999; 28: 324-331.
83. Agomo C etal. An investigation of nicotine replacement therapy provision by community pharmacists in Wandsworth Primary Care Trust, London. Pharm J 2006; 277: 609-611.
84. Aquilino ML etal. Smoking-cessation services in Iowa community pharmacies. Pharmacotherapy 2003; 23: 666-673.